19 related articles for article (PubMed ID: 17695531)
1. Design, synthesis, and evaluation of pH-dependent hydrolyzable emetine analogues as treatment for prostate cancer.
Akinboye ES; Rosen MD; Denmeade SR; Kwabi-Addo B; Bakare O
J Med Chem; 2012 Sep; 55(17):7450-9. PubMed ID: 22867001
[TBL] [Abstract][Full Text] [Related]
2. Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan.
Vogelhuber M; Feyerabend S; Stenzl A; Suedhoff T; Schulze M; Huebner J; Oberneder R; Wieland W; Mueller S; Eichhorn F; Heinzer H; Schmidt K; Baier M; Ruebel A; Birkholz K; Bakhshandeh-Bath A; Andreesen R; Herr W; Reichle A
Cancer Microenviron; 2015 Apr; 8(1):33-41. PubMed ID: 25503648
[TBL] [Abstract][Full Text] [Related]
3. Reversible and irreversible protein glutathionylation: biological and clinical aspects.
Cooper AJ; Pinto JT; Callery PS
Expert Opin Drug Metab Toxicol; 2011 Jul; 7(7):891-910. PubMed ID: 21557709
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of treosulfan and busulfan on pediatric tumor cell lines.
Lanvers-Kaminsky C; Bremer A; Dirksen U; Jürgens H; Boos J
Anticancer Drugs; 2006 Jul; 17(6):657-62. PubMed ID: 16917211
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of digitalis on the proliferation of androgen dependent and independent prostate cancer cells.
Yeh JY; Huang WJ; Kan SF; Wang PS
J Urol; 2001 Nov; 166(5):1937-42. PubMed ID: 11586264
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis of human prostate androgen-dependent and -independent carcinoma cells induced by an isopropanolic extract of black cohosh involves degradation of cytokeratin (CK) 18.
Hostanska K; Nisslein T; Freudenstein J; Reichling J; Saller R
Anticancer Res; 2005; 25(1A):139-47. PubMed ID: 15816531
[TBL] [Abstract][Full Text] [Related]
7. The alkylator treosulfan shows activity towards human renal-cell carcinoma in vivo and in vitro.
Köpf-Maier P
In Vivo; 1998; 12(3):275-88. PubMed ID: 9706471
[TBL] [Abstract][Full Text] [Related]
8. Treosulfan in the treatment of metastatic renal cell carcinoma.
Rigos D; Wechsel HW; Bichler KH
Anticancer Res; 1999; 19(2C):1549-52. PubMed ID: 10365143
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic effects of treosulfan on prostate cancer cell lines.
Feyerabend S; Feil G; Krug J; Kassen A; Stenzl A
Anticancer Res; 2007; 27(4B):2403-8. PubMed ID: 17695531
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of high-dose i.v. treosulfan in children undergoing treosulfan-based preparative regimen for allogeneic haematopoietic SCT.
Główka FK; Karaźniewicz-Łada M; Grund G; Wróbel T; Wachowiak J
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S67-70. PubMed ID: 18978748
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
